American Century Companies Inc. purchased a new stake in Exantas Capital Corp (NYSE:XAN) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 40,800 shares of the company’s stock, valued at approximately $409,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Quantamental Technologies LLC purchased a new position in shares of Exantas Capital in the 4th quarter valued at about $31,000. Legal & General Group Plc increased its holdings in shares of Exantas Capital by 28.8% in the 4th quarter. Legal & General Group Plc now owns 6,214 shares of the company’s stock valued at $62,000 after purchasing an additional 1,390 shares in the last quarter. Metropolitan Life Insurance Co. NY increased its holdings in shares of Exantas Capital by 260.8% in the 4th quarter. Metropolitan Life Insurance Co. NY now owns 8,465 shares of the company’s stock valued at $85,000 after purchasing an additional 6,119 shares in the last quarter. SG Americas Securities LLC purchased a new position in shares of Exantas Capital in the 3rd quarter valued at about $124,000. Finally, Bank of America Corp DE increased its holdings in shares of Exantas Capital by 56.3% in the 4th quarter. Bank of America Corp DE now owns 19,606 shares of the company’s stock valued at $196,000 after purchasing an additional 7,065 shares in the last quarter. Institutional investors and hedge funds own 66.66% of the company’s stock.
Shares of XAN opened at $10.69 on Friday. The company has a quick ratio of 132.44, a current ratio of 132.44 and a debt-to-equity ratio of 2.81. The stock has a market capitalization of $340.51 million, a PE ratio of 15.06 and a beta of 0.80. Exantas Capital Corp has a 52-week low of $9.40 and a 52-week high of $12.09.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be issued a dividend of $0.20 per share. This is an increase from Exantas Capital’s previous quarterly dividend of $0.18. This represents a $0.80 annualized dividend and a yield of 7.48%. The ex-dividend date is Thursday, March 28th. Exantas Capital’s dividend payout ratio (DPR) is 112.68%.
A number of brokerages have recently issued reports on XAN. Zacks Investment Research downgraded shares of Exantas Capital from a “hold” rating to a “sell” rating in a report on Saturday, March 9th. ValuEngine downgraded shares of Exantas Capital from a “buy” rating to a “hold” rating in a report on Friday, March 1st. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $12.63.
TRADEMARK VIOLATION WARNING: This report was reported by WKRB News and is the property of of WKRB News. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://www.wkrb13.com/2019/04/20/american-century-companies-inc-purchases-new-holdings-in-exantas-capital-corp-xan.html.
Exantas Capital Profile
Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments related to commercial real estate (CRE), commercial mortgage-backed securities, and CRE equity investments.
Recommended Story: How do investors use RSI to grade stocks?
Want to see what other hedge funds are holding XAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exantas Capital Corp (NYSE:XAN).
Receive News & Ratings for Exantas Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exantas Capital and related companies with MarketBeat.com's FREE daily email newsletter.